Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Nakamachi: PPARα agonists suppress osteopontin expression in macrophages and decrease plasma.... (0.13 sec) 

PPARα agonists suppress osteopontin expression in macrophages and decrease plasma …

- shouxi.net
T Nakamachi, T Nomiyama, F Gizard, EB … - Diabetes, 2007 - Am Diabetes Assoc
Osteopontin (OPN) is a proinflammatory cytokine implicated in the
chemoattraction of monocytes and the development of atherosclerosis. Peroxisome
proliferator–activated receptor (PPAR) , a ligand-activated transcription ...
Cited by 29 - Related articles - BL Direct - All 5 versions

A simple method to screen ligands of peroxisome proliferator-activated receptor δ


MC Cho, HE Yoon, JW Kang, SW Park, Y Yang … - European journal of pharmaceutical sciences, 2006 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) are transcription factors
that belong to the nuclear receptor superfamily directly modulating gene
expression by binding to specific ligands. Recently, it has been reported ...
Cited by 6 - Related articles - All 5 versions

IL-13 induces expression of CD36 in human monocytes through PPARg activation


A Berry, P Balard, A Coste, D Olagnier, C … - European journal of immunology, 2007 - interscience.wiley.com
The class B scavenger receptor CD36 is a component of the pattern recognition
receptors on monocytes that recognizes a variety of molecules. CD36 expression
in monocytes depends on exposure to soluble mediators. We demonstrate here ...
Cited by 16 - Related articles - BL Direct - All 5 versions

Macrophage Expression of Peroxisome Proliferator Activated Receptor-{alpha} Reduces …

- ahajournals.org
VR Babaev, H Ishiguro, L Ding, PG Yancey, … - Circulation, 2007 - Am Heart Assoc
Methods and Results— To examine the contribution of PPAR expression by bone
marrow–derived cells in atherosclerosis, male and female low-density
lipoprotein receptor–deficient (LDLR –/– ) mice were reconstituted ...
Cited by 15 - Related articles - All 6 versions

Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology- …


L Yue, F Ye, C Gui, H Luo, J Cai, J Shen, K … - Protein Science: A Publication of the Protein Society, 2005 - pubmedcentral.nih.gov
Liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are
two members of nuclear receptors involved in the nutrient metabolisms of dietary
fatty acid and cholesterol. They are found to be of cross-talk function in ...
Cited by 13 - Related articles - All 7 versions

PPARg-dependent regulation of human macrophages in phagocytosis of apoptotic cells


G Majai, Z Sarang, K Csomós, G Zahuczky, L … - European journal of immunology, 2007 - interscience.wiley.com
Macrophages acquire their capacity for efficient phagocytosis of apoptotic cells
during their differentiation from monocytes. The peroxisome
proliferator-activated receptor gamma (PPAR ) is highly up-regulated during ...
Cited by 16 - Related articles - BL Direct - All 4 versions

In vitro farnesoid X receptor ligand sensor assay using surface plasmon resonance and …


T Fujino, Y Sato, M Une, T Kanayasu-Toyoda … - Journal of Steroid Biochemistry and Molecular Biology, 2003 - Elsevier
Ligand binding to nuclear receptors leads to a conformational change that
increases the affinity of the receptors to coactivator proteins. We have
developed a ligand sensor assay for farnesoid X receptor (FXR) in which the ...
Cited by 14 - Related articles - All 5 versions

[PDF] Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders


MC Cho, K Lee, SG Paik, DY Yoon - PPAR research, 2008 - downloads.hindawi.com
Hindawi Publishing Corporation PPAR Research Volume 2008, Article ID 679137, 14
pages doi:10.1155/2008/679137 ... Min-Chul Cho,1 Kyoung Lee,2 Sang-Gi Paik,3
and Do-Young Yoon1 ... 1 Department of Bioscience & Biotechnology, Konkuk ...
Cited by 9 - Related articles - View as HTML - All 9 versions

Plasma osteopontin levels and expression in adipose tissue are increased in obesity

- endojournals.org
J Gomez-Ambrosi, V Catalan, B Ramirez, A … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc
Context: Obesity acts as a cardiovascular risk factor by mechanisms that are not
fully understood. Osteopontin (OPN) is a proinflammatory mediator involved in
tissue remodeling that plays a role in atherosclerosis and diabetes.
Cited by 25 - Related articles - BL Direct - All 6 versions

Peroxisome proliferator-activated receptor γ: its role in metabolic syndrome


R Pakala, P Kuchulakanti, SW Rha, E … - Cardiovascular Radiation Medicine, 2004 - Elsevier
Metabolic syndrome, also known as insulin resistance syndrome, metabolic
syndrome x, and dismetabolic syndrome, refers to a specific clustering of
cardiovascular risk factors [1, 2, 3, 4 and 5]. Patients with metabolic ...
Cited by 14 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google